Obagi Medical - Nu-derm System - Normal To Dry - Skin Transformation Trial Kit
NDC Package 62032-528-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Obagi Medical - Nu-derm System - Normal To Dry - Skin Transformation Trial Kit is use twice daily, morning and evening. Marketed by Obagi Cosmeceuticals Llc, this product is identified by NDC 62032-528.

Identification & Billing

NDC Package Code
62032-528-07
Package Description
1 KIT in 1 CARTON * 57 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 TUBE
Product Code
62032-528
11-Digit Billing Format
62032052807
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Obagi Medical - Nu-derm System - Normal To Dry - Skin Transformation Trial Kit
Dosage Form
-
Usage Information
Use twice daily, morning and evening. Massage a small amount of cleanser and water onto skin. Rinse with lukewarm water and gently pat dry. Use daily, in the morning and evening after cleansing. Shake before use. Saturate a cotton pad and gently wipe over the entire face. Do not rinse. Use daily, in the morning. Squeeze a small amount (approximately 1 to 2 pea-size drops) onto your hands. Using your fingertips, apply evenly to the entire face. Massage until completely absorbed. •apply liberally 15 minutes before sun exposure•use a water resistant sunscreen if swimming or sweating•reapply at least every 2 hours•children under 6 months: Ask a doctor•Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:•limit time in the sun, especially from 10 a.m.–2 p.m.•wear long-sleeved shirts, pants, hats, and sunglasses

Regulatory & Marketing

Labeler Name
Obagi Cosmeceuticals Llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-16-2015
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62032-528-07 identifies a specific commercial package of 1 kit in 1 carton * 57 g in 1 bottle, plastic * 28 g in 1 bottle, plastic * 28 g in 1 tube of Obagi Medical - Nu-derm System - Normal To Dry - Skin Transformation Trial Kit, labeled by Obagi Cosmeceuticals Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Obagi Cosmeceuticals Llc on November 16, 2015. The current certification is valid through December 31, 2022.

How is this Obagi Cosmeceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62032052807. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62032-528-07
11-Digit CMS (5-4-2)
62032-0528-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.